Zoetis Inc. $ZTS Shares Purchased by Level Four Advisory Services LLC

Level Four Advisory Services LLC raised its stake in shares of Zoetis Inc. (NYSE:ZTS) by 38.2% during the second quarter, HoldingsChannel reports. The fund owned 8,462 shares of the company’s stock after acquiring an additional 2,338 shares during the quarter. Level Four Advisory Services LLC’s holdings in Zoetis were worth $1,320,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of ZTS. Savvy Advisors Inc. increased its holdings in Zoetis by 54.0% in the second quarter. Savvy Advisors Inc. now owns 3,177 shares of the company’s stock valued at $495,000 after buying an additional 1,114 shares during the last quarter. Sound Income Strategies LLC grew its position in shares of Zoetis by 54.3% in the 2nd quarter. Sound Income Strategies LLC now owns 432 shares of the company’s stock worth $67,000 after acquiring an additional 152 shares in the last quarter. Canoe Financial LP grew its position in shares of Zoetis by 859.0% in the 2nd quarter. Canoe Financial LP now owns 13,369 shares of the company’s stock worth $2,085,000 after acquiring an additional 11,975 shares in the last quarter. Strs Ohio bought a new stake in shares of Zoetis in the 1st quarter valued at approximately $22,891,000. Finally, Chicago Partners Investment Group LLC raised its position in shares of Zoetis by 67.0% during the 2nd quarter. Chicago Partners Investment Group LLC now owns 4,886 shares of the company’s stock valued at $750,000 after acquiring an additional 1,961 shares in the last quarter. Institutional investors own 92.80% of the company’s stock.

Zoetis Price Performance

Shares of NYSE:ZTS opened at $128.18 on Friday. The firm’s 50 day moving average is $135.77 and its two-hundred day moving average is $149.01. The firm has a market capitalization of $56.49 billion, a P/E ratio of 22.06, a PEG ratio of 2.31 and a beta of 0.90. The company has a current ratio of 1.76, a quick ratio of 1.04 and a debt-to-equity ratio of 1.05. Zoetis Inc. has a 52 week low of $115.25 and a 52 week high of $181.85.

Zoetis (NYSE:ZTS) last issued its quarterly earnings data on Tuesday, November 4th. The company reported $1.70 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.62 by $0.08. Zoetis had a return on equity of 56.90% and a net margin of 27.83%.The business had revenue of $2.40 billion during the quarter, compared to the consensus estimate of $2.42 billion. During the same period in the previous year, the firm posted $1.58 earnings per share. The business’s revenue was up .5% on a year-over-year basis. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. Analysts anticipate that Zoetis Inc. will post 6.07 earnings per share for the current year.

Zoetis Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 2nd. Stockholders of record on Friday, October 31st will be paid a $0.50 dividend. The ex-dividend date of this dividend is Friday, October 31st. This represents a $2.00 annualized dividend and a dividend yield of 1.6%. Zoetis’s dividend payout ratio is presently 33.67%.

Wall Street Analyst Weigh In

A number of equities analysts have commented on ZTS shares. BTIG Research decreased their price objective on shares of Zoetis from $200.00 to $160.00 and set a “buy” rating for the company in a report on Wednesday, November 12th. JPMorgan Chase & Co. reduced their price target on shares of Zoetis from $230.00 to $200.00 and set an “overweight” rating on the stock in a research report on Wednesday, November 5th. Morgan Stanley decreased their price target on shares of Zoetis from $211.00 to $175.00 and set an “overweight” rating for the company in a report on Monday, November 10th. KeyCorp started coverage on shares of Zoetis in a research note on Thursday, November 20th. They set a “sector weight” rating on the stock. Finally, Stifel Nicolaus cut their target price on shares of Zoetis from $140.00 to $130.00 and set a “hold” rating on the stock in a report on Tuesday, November 18th. Six investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $178.89.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.